MONOCLONAL ANTIBODIES DIRECTED AGAINST CYTOKINES
IC Name
DIVISION OF CANCER TREATMENT
-
Activity
N43
-
Administering IC
CM
-
Application Type
1
-
Direct Cost Amount
-
Indirect Cost Amount
-
Total Cost
-
Sub Project Total Cost
-
ARRA Funded
-
CFDA Code
395
-
Ed Inst. Type
-
Funding ICs
-
Funding Mechanism
-
Study Section
-
Study Section Name